With the participation of more than 200 exceptional physicians and researchers, the University of Chicago Medicine Comprehensive Cancer Center is one of just two NCI-designated Comprehensive Cancer Centers in the state. It was founded in 1973, after the establishment of the National Cancer Act, and since then has garnered a remarkable international reputation.
University of Chicago Cancer Center Highlights and Location
- The center aims to foster engagement within the local community in order to educate the public and inform them of the latest in cancer research
- Conducts pioneering clinical trials to test experimental treatments and investigational therapies while identifying new treatment possibilities
- Has the affiliated not-for-profit University of Chicago Cancer Research Foundation (UCCRF) to raise funds for clinical research programs
- UChicago Medicine is affiliated with 12 outstanding Nobel Laureates
- The center is ranked as having one of the top cancer programs in the U.S.
- Awarded a three-year accreditation with commendation by the American College of Surgeons Commission on Cancer
- The center’s cancer program received the highest total rating in seven categories, including prevention and early detection of cancer
- Accredited by the Quality Oncology Practice Initiative (QOPI®), part of the American Society of Clinical Oncology
- The center is a Blue Cross Blue Shield Designated Blue Distinction Center© for “complex and rare cancers”
The University of Chicago Cancer Center is located at:
5841 S Maryland Ave
Chicago, IL 60637, USA
Mesothelioma Treatment at The University of Chicago Cancer Center
“For more than 25 years, the University of Chicago Medicine Comprehensive Cancer Center has been a pioneer in the treatment and research of malignant mesothelioma.”
Mesothelioma is a rare disease, which makes it all the more important that you receive your diagnosis, prognosis information and treatment from a professional who has significant experience with mesothelioma patients. Esteemed institutes such as The University of Chicago Cancer Center can offer the level of expertise and mesothelioma-specific knowledge that most benefits patients. The center has a highly qualified, multidisciplinary team of mesothelioma specialists who combine their expertise and backgrounds to create effective, personalized treatment plans for each and every patient.
Treatment options offered for malignant mesothelioma at The University of Chicago Cancer Center include:
- Radiation Therapy
- Clinical Trials
- Multimodal Therapy
- HIPEC (hyperthermic intraperitoneal chemoperfusion or chemotherapy)
The team of mesothelioma experts at University of Chicago Cancer Center comprises thoracic surgeons, medical oncologists, general surgeons, pathologists, imaging specialists, scientists, and nurses. Each of these medical professionals has a deep understanding of mesothelioma’s specific characteristics and complexities. The team collaborates for meetings on a weekly basis to ensure everyone is on the same page and that there is a consensus on all aspects of the mesothelioma program. In addition, the program has a nurse navigator whose job is to organize and manage the care for mesothelioma patients. All these parameters ensure mesothelioma patients at the center receive a holistic and comprehensive care program that’s weighed in on by experts across all fields.
The main goal of The University of Chicago Cancer Center’s mesothelioma program is to improve patients’ lives and wellbeing while looking for ways to manage the disease. While there is no existing cure for malignant mesothelioma, the program staff are working toward eliminating it as a life-threatening illness and making it manageable so that patients can live longer and more healthily.
Mesothelioma Doctors at University of Chicago Cancer Center
The mesothelioma doctors at University of Chicago Cancer Center can provide patients with the accuracy and knowledge that they deserve to count on in their consultation and care. The following highly qualified medical professionals make up the center’s mesothelioma physician team:
Hedy Kindler, MD
Aliya Husain, MD
Renuka Malik, MD
Heber MacMahon, MB, BCh
Alexandra Funaki, MD
Brent Greenberg, MD
Steven Montner, MD
Christopher Straus, MD
Steven Zangan, MD
Mark Ferguson, MD
Kiran K. Turaga, MD, MPH
Mesothelioma Clinical Trials at University of Chicago Cancer Center
“The testing and use of promising new approaches for mesothelioma–such as chemotherapy, immunotherapies and novel targeted agents, and surgery — is one of our highest priorities. Many of our clinical trials are performed in collaboration with the National Cancer Institute, drug manufacturers, and other institutions. The University of Chicago plays a key role in the conception and evaluation of these treatments, and is positioned to offer the most diverse treatment options to patients.”
The University of Chicago Cancer Center is at the forefront of the latest advancements in mesothelioma therapy, conducting fascinating clinical trials to discover more effective ways of treating mesothelioma. They are looking at new drug combinations, molecular therapy, and dosage levels to identify the most effective methods of combating and managing the disease.
To learn more about participating in a clinical trial for mesothelioma at University of Chicago Cancer Center, call the center toll-free at 1-855-702-8222 or email email@example.com. You can also read more about current, open clinical trials for mesothelioma treatment on the center’s website.
Patient Experience at University of Chicago Medicine’s Comprehensive Cancer Center
Ensuring that patients have a comfortable, informative and high-quality experience is of the highest priority at the University of Chicago Cancer Center. The professionals at the center understand the stress and other associated burdens that come with a cancer diagnosis, and aim to provide patients with an efficient, valuable and comfortable experience during their care.
They are aware of the importance of transparency when it comes to communication with patients and families, and use this to foster strong patient-staff relationships. Patients at the center can be sure that they will fully understand the pros and cons of each treatment option and understand the reasoning behind every medical recommendation.
Cancer patients at the center will also benefit from the institution’s wealth of resources available at their disposal. There is extensive information on clinical trials, survivor resources and even a program to help patients live healthily and quit smoking. In addition, the center offers a myriad of supportive services, understanding that the effects of cancer extend well beyond the physical impacts. There is one-on-one counseling for patients and their loved ones, support groups and support for funding, transportation and accommodation.
Booking Your Appointment at University of Chicago Cancer Center
You can book a preliminary appointment at University of Chicago Cancer Center or request an appointment to get a second opinion from a mesothelioma expert. Obtaining a second opinion is a very important post-diagnosis step, especially for patients with relatively rare cancers such as mesothelioma. The medical team at University of Chicago Cancer Center can recommend leading-edge treatments that are not available at most hospitals.